Wells Fargo sees psychedelics market reaching $11B by 2035 https://www.investing.com/news/stoc...lics-market-reaching-11b-by-2035-93CH-4813495
Big Pharma wants to sell you psychedelic drugs https://spectator.com/article/big-pharma-wants-to-sell-you-psychedelic-drugs/?edition=us
Unlocking the Next Step in Compass’ Journey https://www.linkedin.com/pulse/unlocking-next-step-compass-journey-kabir-nath-d2zxc/
Three potential takeover targets in psychedelics https://www.pharmavoice.com/news/three-potential-takeover-targets-psychedelics-drug/826887/
Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights August 5, 2026 https://ir.compasspathways.com/News...-Results-and-Business-Highlights/default.aspx Data from two positive Phase 3 trials demonstrated rapid onset of effect and durable benefit through at least 6 months, further validating COMP360’s potential to establish a new standard of care in TRD COMP360 has a highly differentiated clinical profile and is expected to be a blockbuster opportunity, if approved Rolling NDA submission and initial review underway and final submission expected to be completed in Q4 Commercial launch expected in first half of 2027 COMP360 expected to fit seamlessly into current treatment infrastructure Late-stage PTSD trial underway Strong cash position of $433 million at the end of second quarter, providing cash well beyond launch and into 2028 Compass management will host a conference call on August 5 at 8:00 am ET
COMPASS Pathways investor presentation August 2026 https://s204.q4cdn.com/927483861/files/doc_presentation/2026/07/FINAL_CMPS_IR-Deck_AUG2026.pdf
Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin https://ir.compasspathways.com/News...estigational-Study-of-Psilocybin/default.aspx
